Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04771221Not ApplicableCompleted

Method of Early Diagnosis of Laryngopharyngeal Reflux

Role: lead

NCT04630327Completed

Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory

Role: lead

NCT05296655Completed

Kazakh Version of Reflux Symptom Index

Role: lead

NCT05011409Completed

Prevalence of Depression and Anxiety Among Breast Cancer Patients

Role: lead

All 4 trials loaded